2 stories tagged by Digg
Science
STAT reports the companies are teaming up to test ivonescimab, a PD-1/VEGF bispecific drug, alongside AstraZeneca’s antibody-drug conjugates.
World & Business
Barron's says the deal would give AstraZeneca exposure to a cancer treatment it describes as promising, without buying Summit outright.
